<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-20T15:57:45Z</responseDate><request verb="GetRecord" identifier="oai:openscholar.dut.ac.za:10321/4467" metadataPrefix="oai_dc">https://openscholar.dut.ac.za/server/oai/request</request><GetRecord><record><header><identifier>oai:openscholar.dut.ac.za:10321/4467</identifier><datestamp>2025-04-03T01:02:28Z</datestamp><setSpec>com_10321_11</setSpec><setSpec>col_10321_12</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Evaluating the effectiveness of virtual buddy support to improve treatment adherence for patients suffering from schizophrenia in KwaZulu-Natal: a model of care</dc:title>
   <dc:creator>Mvunelo, Nomhle</dc:creator>
   <dc:contributor>Haffejee, Firoza</dc:contributor>
   <dc:contributor>Thandar, Yasmeen</dc:contributor>
   <dc:subject>Compliance to antipsychotic medications</dc:subject>
   <dc:subject>Non-adherence to antipsychotics</dc:subject>
   <dc:subject>Schizophrenia</dc:subject>
   <dc:subject>Treatment buddy</dc:subject>
   <dc:subject>Antipsychotics</dc:subject>
   <dc:subject>Schizophrenia</dc:subject>
   <dc:subject>Mental illness</dc:subject>
   <dc:subject>Schizophrenia--Treatment</dc:subject>
   <dc:subject>Personality disorders</dc:subject>
   <dc:subject>Psychology, Pathological</dc:subject>
   <dc:description>Thesis submitted in fulfillment of the requirements for the Doctor of Philosophy in Health Sciences, Durban University of Technology, Durban, South Africa, 2022.</dc:description>
   <dc:description>Background: Psychiatric patients that are suffering from schizophrenia disorder are&#xd;
prescribed antipsychotic medications which are the first line treatment strategy for this&#xd;
disorder. Research has revealed that schizophrenic patients struggle to adhere to their&#xd;
prescribed medication. Interventions to promote adherence to these medications are&#xd;
required. One intervention suggested, which is new in psychiatry, is the use of treatment&#xd;
buddy services. This study investigated the effectiveness of virtual treatment buddy&#xd;
support in improving adherence to antipsychotic medications amongst patient diagnosed&#xd;
with schizophrenia disorder.&#xd;
Methods: A mixed methods approach was utilized. A total of 117 schizophrenic patients&#xd;
were recruited from a selected psychiatric clinic in KwaZulu-Natal to participate in this&#xd;
study. From this cohort of participants, 82 were allocated to an intervention group which&#xd;
was provided with treatment buddy support and the remaining 35 formed the control&#xd;
group and did not receive any treatment buddy support. A research assistant was&#xd;
employed to act as a treatment buddy; she sent text message reminders to the&#xd;
participants on a daily basis between 6am and 7am for a period of six months. She also&#xd;
attended to telephonic queries made by participants. Quantitative questionnaires and&#xd;
qualitative interviews were used to collect data. Quantitative data was analyzed using&#xd;
SPSS Version 20.0, and qualitative data was analyzed using thematic analysis.&#xd;
Results: The implementation of treatment buddy support improved adherence to&#xd;
antipsychotic medication from 60.7% pre-intervention to 86.1% post intervention. Some&#xd;
of the reported obstacles to antipsychotic adherence included long duration of treatment&#xd;
(50%), having no cure for the disorder (39.3%), medication side effects (47.7%), not&#xd;
understanding the instructions regarding taking of medications (40.9%) and experience&#xd;
of odd feelings while continuing with treatment (45.5%). Themes that emanated from&#xd;
qualitative interviews supported the quantitative findings that virtual treatment “buddy&#xd;
services” had improved adherence to antipsychotic drugs. Other themes identified, were&#xd;
improved support from clinic, and alleviation of other schizophrenia related problems. The&#xd;
treatment buddy services were also supported by nurses and the research assistant. &#xd;
Conclusion: Implementation of treatment buddy support to patients suffering from&#xd;
schizophrenia was accepted by the patients and nurses and have improved adherence&#xd;
to antipsychotic medications. Implementing treatment buddies can benefit health care&#xd;
institutions, communities, and the health care system at large.</dc:description>
   <dc:description>D</dc:description>
   <dc:date>2022-11-03T08:11:35Z</dc:date>
   <dc:date>2022-11-03T08:11:35Z</dc:date>
   <dc:date>2022-09-29</dc:date>
   <dc:type>Thesis</dc:type>
   <dc:identifier>https://hdl.handle.net/10321/4467</dc:identifier>
   <dc:identifier>https://doi.org/10.51415/10321/4467</dc:identifier>
   <dc:language>en</dc:language>
   <dc:format>229 p</dc:format>
   <dc:format>application/pdf</dc:format>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>